Myokines: The endocrine coupling of skeletal muscle and bone
M Gomarasca, G Banfi, G Lombardi - Advances in clinical chemistry, 2020 - Elsevier
Bone and skeletal muscle are integrated organs and their coupling has been considered
mainly a mechanical one in which bone serves as attachment site to muscle while muscle …
mainly a mechanical one in which bone serves as attachment site to muscle while muscle …
Muscular dystrophies
E Mercuri, F Muntoni - The Lancet, 2013 - thelancet.com
Muscular dystrophies are a heterogeneous group of inherited disorders that share similar
clinical features and dystrophic changes on muscle biopsy. An improved understanding of …
clinical features and dystrophic changes on muscle biopsy. An improved understanding of …
Muscle-bone interactions: From experimental models to the clinic? A critical update
MR Laurent, V Dubois, F Claessens… - Molecular and cellular …, 2016 - Elsevier
Bone is a biomechanical tissue shaped by forces from muscles and gravitation.
Simultaneous bone and muscle decay and dysfunction (osteosarcopenia or sarco …
Simultaneous bone and muscle decay and dysfunction (osteosarcopenia or sarco …
The JAK/STAT pathway in skeletal muscle pathophysiology
V Moresi, S Adamo, L Berghella - Frontiers in physiology, 2019 - frontiersin.org
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is a
key intracellular mediator of a variety of metabolically relevant hormones and cytokines …
key intracellular mediator of a variety of metabolically relevant hormones and cytokines …
Effects of neurological disorders on bone health
RR Kelly, SJ Sidles, AC LaRue - Frontiers in psychology, 2020 - frontiersin.org
Neurological diseases, particularly in the context of aging, have serious impacts on quality of
life and can negatively affect bone health. The brain-bone axis is critically important for …
life and can negatively affect bone health. The brain-bone axis is critically important for …
Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy
B De Paepe, JL De Bleecker - Mediators of inflammation, 2013 - Wiley Online Library
Duchenne muscular dystrophy is a severe inherited muscle disease that affects 1 in 3500
boys worldwide. Infiltration of skeletal muscle by inflammatory cells is an important facet of …
boys worldwide. Infiltration of skeletal muscle by inflammatory cells is an important facet of …
Complexity of skeletal muscle degeneration: Multi-systems pathophysiology and organ crosstalk in dystrophinopathy
K Ohlendieck, D Swandulla - Pflügers Archiv-European Journal of …, 2021 - Springer
Duchenne muscular dystrophy is a highly progressive muscle wasting disorder due to
primary abnormalities in one of the largest genes in the human genome, the DMD gene …
primary abnormalities in one of the largest genes in the human genome, the DMD gene …
Interdependence of muscle atrophy and bone loss induced by mechanical unloading
SA Lloyd, CH Lang, Y Zhang, EM Paul… - Journal of bone and …, 2014 - academic.oup.com
Mechanical unloading induces muscle atrophy and bone loss; however, the time course and
interdependence of these effects is not well defined. We subjected 4‐month‐old C57BL/6J …
interdependence of these effects is not well defined. We subjected 4‐month‐old C57BL/6J …
[HTML][HTML] Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response
S Gandhi, HL Sweeney, CC Hart, R Han, CGR Perry - Cells, 2024 - mdpi.com
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
LS Conklin, JM Damsker, EP Hoffman, WJ Jusko… - Pharmacological …, 2018 - Elsevier
We report a first-in-patient study of vamorolone, a first-in-class dissociative steroidal anti-
inflammatory drug, in Duchenne muscular dystrophy. This 2-week, open-label Phase IIa …
inflammatory drug, in Duchenne muscular dystrophy. This 2-week, open-label Phase IIa …